Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
KYAWZIN HAN
U a?k 6I ,.** ++
-o
Bifth Date: 12105/1983 Age: 36 Y 9 M 9 D Sex: {.tfl (Male)
-=o
:@
Chief Complaint
Diagnosis (ln case of skin lesion specify the ocation)
\{
W\( at U' /^(S
Treatment / lnvestigation
o
Physician's 9552
Date _Time.
lDR,SURACHAT
I acknowledge all risks during travel by aircraft from physician and voluntary to accept my own risk if I travel against the
medical advices.
SignatUrePatientSignaturePatient,sRelative
[/R. KYAW ZIN HAN
Remark : Please mark " N/A" under the item that is not applicable. Scanned by
I
Name:MR. KYAW ZIN HAN Nationality: MYANMAR z
ffi
g.g$
qr4n
i;::
r', r
-. :,* T
urrrn,l"lstn ta< .rllqqr i-.r,i ll l:a
" HN:01-19-040389 ;
'
Phvsician:DR.SIRIMONPIYAVUNNO
30211 @
O
Visit Date: 1810212020 Department: Ward 5W "
O
';irulw
-,",
R\ffi'.ffi
r01 -20-0003385
Medical Certificate Page: [A'1]
-
Physician/ Dentist name DR.SIRIMON PIYAVUNNO Medical/ Dental License No. 30211
at Bangkok Hospital, 2 Soi Soonvijai 7, New Petchburi Road, Bangkok
m
z
_
(Patient) o
I have examined Mr./Mrs./Miss MR. KYAW ZIN HAN N
o
O
O
O
o
Has been treated on o
f] out-Patient Date:
El ln-Patient AN: 101-20-0003385 Date..1Bt02t2020
Diagnosis
d-rit^,t(.+iti L(.- r-. -". \,-. :o
0 --', :1, :>
-o
:N
:
lTreatment / lnvestigation
nro."oure :
In
l-l
r_l
l
-
I fl srrsery
l?o,n"''W."'-
l
I
I O
lR""orr"ndation
I
o
" ':. \
\
lE *".orr"n ;[ \'';'* 4
I
| , ..-I+.
'i+-'j j"i'::"
I
l'--)/
I
-
- .ionature
;L" 3 M.D / D.D.s
|( --
Medical License ne. 30211
Remark : Please mark " N/A" under the item that is not applicable. Scanned by
Name: MR. KYAW ZIN HAN Nationaltty: l/YANMAR f
z
HN: O1-19-040389 ;
Visit Date: rclA2l202o o
O
a
Birth Date:12105/1983 Age:36YgM9D Sex: tret (Male)
@
@
t01 -20-0003385
Medical Certificate
Page:lA1l -
Physician/ Dentist name DR,SURACHAT CHAKRAPEE-SIRISUK Medical/ Dentat License No. 9552
at Bangkok Hospital, 2 Soi Soonvijai 7, New Petchburi Road, Bangkok m
,ZIout-Patient Date:
Chief Compl
Diaonosis
-/*n c-4
) ns^,ur"-^ r- /k{.r{,*- Jr--(
C
ftt(wrfilYltV. .)
o
U @
N
O
N
O
O
N
N
N
N
O
-1
Treatment / lnvestigation
rEI Medication dx-a^y 'il rro
E Dressing n PhysicatTherapy
E Procedure
E srrg"ry-
).t i v I t
p'otner ,t'(*.
O
Recommendation
I Patient need to rest for .Days
O
@
,c9
O
From Date To Date !t
=
E Recommendation
-+ I
M.D / D.D.S
Remark i Please mark " N/A" under the item that is not applicable. Scanned by
ilr Mrillllllll lll lllllllllll lll lll ilt r I lll I ll ll lllllll I llll lll I llll ll lllll I lll ll lll ili m I mil mll Illlll llll I lll I ll ll I ll ll ll lllll lll ilt lilliltilr llll llllll I lll
01 '14098t01CANCEN HN : 01 19040389
EN : O01 191004484 |ANX1220220201211
E.E* BANGKOK z
- "loflnutti{u z nuurvrqet.llfr'prluH nr.irvl1,'r 10310
Soi S'oonvilai Z New petJnaOuri Rd. Bangkok 10310 Thailand
r-9 uosPlrAl Tel, 66-231 0-3000 Fax. 66-231 B-1 546
Contact Center Tel. 1719
www. ba ng kokhos pital. co m
Room No. :
Allergies
No known allergY
Chief Complaint
Jaundice, cough.
History of Present lllness
He first came to see Hematologist atWattanosoth Hospital, Bangkok Hospital Medical center
on 161712019 due
recommended.
Spleen : No change in size and appearance of the spleen since the previous study,
measuring about 15.0.18.5 cm in axial dimensions and21.0 cm in vertical span, with clusters
of small nodules with dense rim in lower and central regions. Overall splenic perfusion is less
than that of the liver and the nodules are barely enhanced. The splenic vein is not opacified.
Liver : Presence of a few cysts in segment 2 and 4 with no other maSS.
GB and biliary : No gall stones. No dilatation of intrahepatic ducts or CBD,
Pancreas, adrenal, kidneys, bladder : Normal.
(normal
Gl tract : Displacement of the DJ unction almost to the right border of the spine
position at left of spine) and compression of the proximal part of the stomach. Small bowel
and colon less affected. No bowel obstruction'
Others : No rntraabdominal adenopathy. Minimal free fluid in the pelvic cavity.
Basal chest : No lung nodule or pleural effusion'
probably
Bone : Multiple tiny sclerotic foci in the bones, better outlined on this study but
unchanged. No abnormal bone trabeculation. No fracture or epidural mass'
IMPRESSION :
Hethe developJaundice, cough in early Fel:2020, Lab in Myanmar on111212020 PT26 (<12), Hb 9.8, Hct
29.8%, Ptt46,000 Biti-T 87.4 (<18.8), ALp 453 (<129), SGPT 120 (<41), SGOT 170(<40),
He came on171212020. Nofever, Drycough, RUQ pain, anorexia.ModeratelyJaunduce, Liver4 FB below RCM,
PET/CT scan reported new developed numerous small non FDG avid bilateral pulmonary metastases.
Diffuse metastases in both lobes of liver.
Widespread bone metastases throughout the whole axial bone, both femora and humeri.
He was admitted for further evaluation and supportive treatment.
Discharge Diagnosis
(1) Principal Diagnosis
AngioSarcoma of spleen post Splenectomy. Hyperprogressive metastases.
Jaundice
(2) Secondary Diagnosis / Co morbidity
Anemia with Thrombocytopenia
Relevant investigation results
ResultRadiology
171212020 Chest PA Result:
COMPARISON: '15i1 112019, FINDINGS:Apparent diffuse coarse trabeculation of the osseous structures;
could be due to hematological disease or marrow disease.Diffuse increased pulmonary marking in both
lungs; still shown.However diffuse fine reticular infiltration in both lungs should be considered.No recent
gross pleural effusion.Normal heart size and airta.
I nd ication : Restag i n g.
Radiopharmaceutical: 1BF-FDG Total activity: 10.3s2 mci
Blood Sugar: 112 mgldl.
Findings of CT Scan :
Contrast enhanced CT scan was perlormed from the skull vertex to both thighs and compared to previous
cr abdomen on 15 oct 20'19 from other hospitar and pET/cr on 1 7 July 201g.
The brain study appears normal. The head and neck structures including thyroid gland are unremarkable.
There is no cervical or supraclavicular adenopathy.
The lung shows interval developed numerous small target-like subsolid nodules scattered in
both lungs
such as a 0.4 cm nodule surrounded with ground-glass at RLL (Se 7; IMA 84). There is no pleural effusion.
No mediastinal or hilar adenopathy is noted. The heart and other mediastinal structures are normal.
The
chest wall and axillae are unremarkable.
Splenectomy has been done. Hepatomegaly with numerous hypoattenuated nodules & masses in both
lobes of liver are developed such as a 6.8 cm mass at segment 3 (Se 4; IMA 116), a 2.6 cm nodule in
segment4 (lN/A 121) and a 1.9 cm nodule in segment 6 (lMA 131). The portal vein is patent. No bite duct
dilatation is seen.
The GB is collapsed. The pancreas, adrenal glands and both kidneys are unremarkable. The pelvic
structures appear normal. The Gl tract is within normal limits. No intraabdominal, paraaortic or pelvic
adenopathy is visualized. Minimal ascites is present.
Diffuse ill-defined lytic lesions throughout the whole skeleton are detected. Focal lytic lesion with minimal
left paravertebralsofttissue at L1 body is observed, about 3 cm in size (lMA 124). No epidural extension is
seen.
Findings of PET Scan :
The attenuation corrected FDG PET is performed from vertex of skull to upper thighs at 60 min after
intravenous injection of the radiotracer.
The follow up study is compared to the previous pET-cr study on llJuly 201g.
ln the brain: The study shows no FDG avid lesion in each cerebral hemisphere.
ln cervicalarea: There is no hypermetabolic activity in nasopharynx, larynx or in oral cavity. No FDG avid
lymph node in cervical or in supraclavicular space is seen.
ln the thorax: New developed multiple small subsolid nodules scattering in both lungs seen in CT scan
show no increased FDG avidity. No hypermetabolic node in mediastinum or hilum is observed.
ln the abdomen: There is newly and irregularly increased FDG uptake in numerous nodules scattering in
both lobes of liver. No hypermetabolic lymph node in retroperitoneal space or in abdomen is detected.
Tracer uptake in pancreas and adrenal gland is unremarkable. No uptake at splenic bed is seen because
of splenectomy.
ln the musculoskeletal system:There is new development of hypermetabolic activity throughout the whole
EN: 00'1191004484 1ANX42202202A1211 0I14O9B;01CANCEN HN;011e04038e
skeleton.
PET/CT IMPRESSION:
ComparedtothepreviousPET-CTstudyon JulylT,20.lg,therearenewdevelopednumeroussmall non
FDG avid bilateral pulmonary metastases.
Diffuse metastases in both lobes of liver.
Widespread bone metastases throughout the whole axial bone, both femora and humeri.
Complete Blood Count
22 Feb 2020 05:53
Hemoglobin (Hb) 8.4 g/dL (13-18)
Corrected WBC 7.49 *'10^3/mm3 (4-10)
Total WBC 13.26.10^3/mm3 (4-10)
Platelet Count 34 10^3/mm3 (150-450)
Red Blood Cell 3.48 .'10^6/mm3 (4.5-5.9)
Hematocrit (Hct) 26.8 % (40-54)
MCV 77 .1 fL (80-100)
MCH 24.1 pg (26-34)
N/CHC 31.2gtdL (31-37)
% Neutroph n 73.1 % (46.5-75)
Neutrophils 9693 /mm3 (2000-7500)
% Lymphocyle 17.7 % (12-44)
Lymphocytes 2347 /mm3 (1500-4000)
% Monocyte 8.1 % (0-11.2)
Monocytes 1074 lmm3 (200-1000)
% Eosinophil 0.6 % (0-9.5)
Eosinophils 80 /mm3 (40-700)
% Basophil 0.5 % (0-2.5)
Basophils 66 /mm3 (0-200)
NRBC 77 l100wbc
RDW 25.8 % (e-15)
MPV 7.3 fL (6-12)
Platelet Count by Manaul Slide Review 3
Platelet Comment Decrease
RBC Morphology Abnormal RBC morphology seen see comment below
Giant Platelet Seen
Hypochromia 1
Microcytosis 1
Polychromasia 1
EN: 001191004484 1ANX5220220201211 0.114098;01CANCEN HN:0119040389
Ovalocytosis Few
Target Cell 1
Schistocyte Few
LD H(Lactate Dehydrogenase)
17 Feb 2020 11'.30
LDH(Lactate Dehydrogenase) 946 U/L (125-220)
Hemoglobin Typing
17 Fel:2020 11'.30
MCV 76.4 fL (80-100)
MCr,23.7 pg (26-34)
Hb typing A2A, Not rule out Alpha Thalassemia: Plese confirm Alpha Thalassemia by PCR method.
CF test Positive.
Hb 42 1.9 % (0-3.5)
Hb A 98.1 %
Leukodepleted Single Donor Platelet-Closed System (SDPCL) 1 Unit
22 Feb 2020 08:45
Blood Group BP
Sodium
17 Fet> 2020 11'.30
Sodium '135 mmol/L (136-145)
Coagulation Profile
17 Feb 202011'.30
.17.1
Prothrombin Time (PT) Secs. (10.5-13.4)
tNR 1.52
APTT 31.3 Secs. (22.5-31.6)
Thrombin Time (TT) 19 Secs. (15-22)
Coag comment Repeated result
Specimen type 3.2
Mean of Reference Range 26.96 Secs.
Creatinine (plus eGFR)
17 Feb 2020 11'.30
Creatinine 0.71 mg/dl (.73-1.18)
eGFR for Thai 136.22 ml/min/1 .73 m2
eGFR (African-American) 139.89 ml/min/1 .73 m2
eGFR (Non African-American) 120.7 mlimin/1 .73 m2
eGFR Comment Calculated by CKD - EPI formula according to National kidney foundation
recommendation. This equation should only be used for patients'18 and older.
ill I illllllillllt ilt ilililil il Ill ilt IIiltI[ [ ililt illll]lillililill]tllil I]t lll llllilllllll lilllllilmll I lil I Il r il il [ ilil ]r lil IililililtilltilIilIlil
EN : O01 1 91 004484 14NX6224220241211 01 '14098;0'l CANCEN HN : 01'1S040389
Microcytosis'1
Polychromasia 1
Ovalocytosis Few
Target Cell '1
Next Generation gene sequencing from prior tissue or new biopy tissue was discussed.
Liquid Biopsy from blood sample (with faster result and less risky compare to new biopsy) was finally
done.
Blood transfusion as LDPRC, SDP were given to the patient to keep level of Hemoglobin >B gm/dl and platelet
count > 20,000 mm3 ( or > 60,000/mm3 during air-traveling )
Patient was discharged.
Waiting for Liquid Biopsy result.
Treatment Plan
Supportive care
Discharge lnstructions / Recommendations
At his home town, He need to be taken care by Gl doctor, oncologist.
Follow - up Arrangements
With SURACHAT CHAKRAPEE-SIRISUK,M D.
Discharge Medication
See Home Medication Sheet
Patient's condition upon discharge
lmproved
Type of Discharge
With Approval
il;;;;.m,;ifu1 -..- -.
Medical License No.9552 .